A carregar...
Modeling the interaction between danoprevir and mericitabine in the treatment of chronic HCV infection
Modeling HCV RNA decline kinetics under therapy has proven useful for characterizing treatment effectiveness. Here we model HCV viral kinetics (VK) in 72 patients given a combination of danoprevir, a protease inhibitor and mericitabine, a nucleoside polymerase inhibitor for 14 days in the INFORM-1 t...
Na minha lista:
| Publicado no: | Antivir Ther |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4862948/ https://ncbi.nlm.nih.gov/pubmed/26555159 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3851/IMP3006 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|